Voyager Therapeutics Inc (VYGR)
5.43
+0.07
(+1.31%)
USD |
NASDAQ |
Nov 21, 16:00
5.69
+0.26
(+4.79%)
Pre-Market: 09:14
Voyager Therapeutics Total Liabilities (Quarterly): 95.73M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 95.73M |
| June 30, 2024 | 100.81M |
| March 31, 2024 | 128.71M |
| December 31, 2023 | 114.96M |
| September 30, 2023 | 118.43M |
| June 30, 2023 | 116.51M |
| March 31, 2023 | 119.33M |
| December 31, 2022 | 100.34M |
| September 30, 2022 | 102.66M |
| June 30, 2022 | 128.55M |
| March 31, 2022 | 148.25M |
| December 31, 2021 | 98.80M |
| September 30, 2021 | 97.35M |
| June 30, 2021 | 98.19M |
| March 31, 2021 | 101.51M |
| December 31, 2020 | 107.26M |
| September 30, 2020 | 103.52M |
| June 30, 2020 | 220.57M |
| March 31, 2020 | 242.85M |
| December 31, 2019 | 255.25M |
| Date | Value |
|---|---|
| September 30, 2019 | 268.06M |
| June 30, 2019 | 270.19M |
| March 31, 2019 | 310.66M |
| December 31, 2018 | 130.58M |
| September 30, 2018 | 131.48M |
| June 30, 2018 | 132.69M |
| March 31, 2018 | 136.73M |
| December 31, 2017 | 50.43M |
| September 30, 2017 | 55.71M |
| June 30, 2017 | 53.12M |
| March 31, 2017 | 52.39M |
| December 31, 2016 | 53.64M |
| September 30, 2016 | 52.86M |
| June 30, 2016 | 54.11M |
| March 31, 2016 | 56.38M |
| December 31, 2015 | 60.38M |
| September 30, 2015 | 64.72M |
| June 30, 2015 | 69.05M |
| December 31, 2014 | 10.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
95.73M
Minimum
Sep 2024
255.25M
Maximum
Dec 2019
129.98M
Average
111.11M
Median
Total Liabilities (Quarterly) Benchmarks
| Rhythm Pharmaceuticals Inc | 352.36M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 426.04M |
| Shareholders Equity (Quarterly) | 330.31M |
| Current Ratio | 8.447 |